Table 2.
Tumour type | Group | n | R2 | p-value |
---|---|---|---|---|
Hepatocellular carcinoma, |
|
|
|
|
Nakajima et al.
[27] |
WD |
19 |
0.001 |
0.5 |
|
MD |
9 |
0.063 |
0.3 |
|
PD |
6 |
0.441 |
0.1 |
|
CS I |
17 |
0.040 |
0.2 |
|
CS II |
15 |
0.009 |
0.4 |
|
WD & CS I |
8 |
0.030 |
0.3 |
WD & CS II | 10 | 0.001 | 0.5 |
Tumours were grouped according to differentiation and clinical stage. None of the correlations were significant. WD: Well differentiated. MD: Moderately differentiated. PD: poorly differentiated. CS: Clinical stage. n: number of tumours. R: correlation coefficient.